{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T15:51:27Z","timestamp":1746114687778},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Robert Koch-Institut"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>SARS-CoV-2 cases in Germany increased in early March 2020. By April 2020, cases among health care workers (HCW) were detected across departments at a tertiary care hospital in Berlin, prompting a longitudinal investigation to assess HCW SARS-CoV-2 serostatus with an improved testing strategy and associated risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In May\/June and December 2020, HCWs voluntarily provided blood for serology and nasopharyngeal\/oropharyngeal (NP\/OP) samples for real-time polymerase chain reaction (PCR) and completed a questionnaire. A four-tiered SARS-CoV-2 serological testing strategy including two different enzyme-linked immunosorbent assays (ELISA) and biological neutralization test (NT) was used. ELISA-NT correlation was assessed using Pearson\u2019s correlation coefficient. Sociodemographic and occupational factors associated with seropositivity were assessed with multivariate logistic regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In May\/June, 18\/1477 (1.2%) HCWs were SARS-CoV-2 seropositive, followed by 56\/1223 (4.6%) in December. Among those tested in both, all seropositive in May\/June remained seropositive by ELISA and positive by NT after 6\u00a0months. ELISA ratios correlated well with NT titres in May\/June (R\u2009=\u20090.79) but less so in December (R\u2009=\u20090.41). Those seropositive reporting a past SARS-CoV-2 positive PCR result increased from 44.4% in May\/June to 85.7% in December. HCWs with higher occupational risk (based on profession and working site), nurses, males, and those self-reporting COVID-19-like symptoms had significantly higher odds of seropositivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This investigation provides insight into the burden of HCW infection in this local outbreak context and the antibody dynamics over time with an improved robust testing strategy. It also highlights the continued need for effective infection control measures particularly among HCWs with higher occupational risk.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07057-3","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T09:04:18Z","timestamp":1643015058000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Longitudinal SARS-CoV-2 seroepidemiological investigation among healthcare workers at a tertiary care hospital in Germany"],"prefix":"10.1186","volume":"22","author":[{"given":"Sara","family":"Tomczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"H\u00f6nning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Hermes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marica","family":"Grossegesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthold","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Eckmanns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajo","family":"Schmidt-Traub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Zappel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"7057_CR1","unstructured":"WHO Director-General's opening remarks at the media briefing on COVID-19: 11 March 2020 [press release]. Available from: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020."},{"issue":"April","key":"7057_CR2","first-page":"8","volume":"15","author":"J Schilling","year":"2021","unstructured":"Schilling J, Buda S, Fischer M, Goerlitz L, Grote U, Haas W, et al. Retrospektive Phaseneinteilung der COVID-19-Pandemie in Deutschland bis Februar 2021. Epid Bull. 2021;15(April):8\u201317.","journal-title":"Epid Bull"},{"issue":"6","key":"7057_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1055\/a-1153-9710","volume":"74","author":"B Wiesner","year":"2020","unstructured":"Wiesner B, Bachmann M, Blum TG, Forchheim S, Geiseler J, Kassin A, et al. Responsibilities of weaning centers during the COVID-19 pandemic outbreak\u2014recommendations for the assignment of ICU capacities in COVID-19 patients as shown by the Berlin-Brandenburg POST-SAVE-Model. Pneumologie. 2020;74(6):358\u201365.","journal-title":"Pneumologie"},{"issue":"15","key":"7057_CR4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/cid\/ciaa255","volume":"71","author":"J Schwartz","year":"2020","unstructured":"Schwartz J, King C-C, Yen M-Y. Protecting healthcare workers during the coronavirus disease 2019 (COVID-19) outbreak: lessons from Taiwan\u2019s severe acute respiratory syndrome response. Clin Infect Dis. 2020;71(15):858\u201360.","journal-title":"Clin Infect Dis"},{"key":"7057_CR5","first-page":"Cd011621","volume":"4","author":"JH Verbeek","year":"2016","unstructured":"Verbeek JH, Ljaz S, Mischke C, Ruotsalainen JH, M\u00e4kel\u00e4 E, Neuvonen K, et al. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database Syst Rev. 2016;4:Cd011621.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"7057_CR6","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/S2213-2600(20)30066-7","volume":"8","author":"D Chang","year":"2020","unstructured":"Chang D, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med. 2020;8(3):e13.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"7057_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jhin.2020.03.002","volume":"105","author":"J Wang","year":"2020","unstructured":"Wang J, Zhou M, Liu F. Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China. J Hosp Infect. 2020;105(1):100\u20131.","journal-title":"J Hosp Infect"},{"key":"7057_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jhin.2020.11.008","volume":"108","author":"P Galanis","year":"2021","unstructured":"Galanis P, Vraka I, Fragkou D, Bilali A, Kaitelidou D. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis. J Hosp Infect. 2021;108:120\u201334.","journal-title":"J Hosp Infect"},{"issue":"1","key":"7057_CR9","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1038\/s41467-020-18848-0","volume":"11","author":"AS Rudberg","year":"2020","unstructured":"Rudberg AS, Havervall S, M\u00e5nberg A, Jernbom Falk A, Aguilera K, Ng H, et al. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020;11(1):5064.","journal-title":"Nat Commun"},{"issue":"2","key":"7057_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1017\/ice.2020.402","volume":"42","author":"JJ Grant","year":"2021","unstructured":"Grant JJ, Wilmore SMS, McCann NS, Donnelly O, Lai RWL, Kinsella MJ, et al. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust. Infect Control Hosp Epidemiol. 2021;42(2):212\u20134.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"7057_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12985-021-01559-3","volume":"18","author":"J Michel","year":"2021","unstructured":"Michel J, Neumann M, Krause E, Rinner T, Muzeniek T, Grossegesse M, et al. Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2. Virol J. 2021;18(1):110.","journal-title":"Virol J"},{"key":"7057_CR12","unstructured":"Centers for Disease Control and Prevention. Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic 2021. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/infection-control-recommendations.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Finfection-control%2Fcontrol-recommendations.html."},{"issue":"4","key":"7057_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/aje\/kws412","volume":"177","author":"D Westreich","year":"2013","unstructured":"Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol. 2013;177(4):292\u20138.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"7057_CR14","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.3390\/ijerph18083910","volume":"18","author":"K M\u00fcller","year":"2021","unstructured":"M\u00fcller K, Girl P, Ruhnke M, Spranger M, Kaier K, von Buttlar H, et al. SARS-CoV-2 seroprevalence among health care workers\u2014a voluntary screening study in a regional medical center in Southern Germany. Int J Environ Res Public Health. 2021;18(8):3910.","journal-title":"Int J Environ Res Public Health"},{"key":"7057_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijid.2020.10.026","volume":"102","author":"J Herzberg","year":"2021","unstructured":"Herzberg J, Vollmer T, Fischer B, Becher H, Becker A-K, Sahly H, et al. Prospective sero-epidemiological evaluation of SARS-CoV-2 among health care workers in a German Secondary Care Hospital. Int J Infect Dis. 2021;102:136\u201343.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"7057_CR16","doi-asserted-by":"publisher","first-page":"e0248813","DOI":"10.1371\/journal.pone.0248813","volume":"16","author":"D Kindgen-Milles","year":"2021","unstructured":"Kindgen-Milles D, Brandenburger T, Braun JFW, Cleff C, Moussazadeh K, Mrosewski I, et al. Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV). PLoS ONE. 2021;16(4):e0248813.","journal-title":"PLoS ONE"},{"issue":"9","key":"7057_CR17","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.3390\/ijerph18094540","volume":"18","author":"J Korth","year":"2021","unstructured":"Korth J, Wilde B, Dolff S, Frisch J, Jahn M, Krawczyk A, et al. SARS-CoV-2 seroprevalence in healthcare workers in Germany: a follow-up study. Int J Environ Res Public Health. 2021;18(9):4540.","journal-title":"Int J Environ Res Public Health"},{"issue":"13","key":"7057_CR18","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.3390\/ijerph18137057","volume":"18","author":"L Larrib\u00e8re","year":"2021","unstructured":"Larrib\u00e8re L, Gordejeva J, Kuhnhenn L, Kurscheidt M, Pobiruchin M, Vladimirova D, et al. Assessment of SARS-CoV-2 infection among healthcare workers of a German COVID-19 Treatment Center. Int J Environ Res Public Health. 2021;18(13):7057.","journal-title":"Int J Environ Res Public Health"},{"key":"7057_CR19","doi-asserted-by":"publisher","first-page":"113771","DOI":"10.1016\/j.ijheh.2021.113771","volume":"235","author":"A Hildebrandt","year":"2021","unstructured":"Hildebrandt A, H\u00f6kelekli O, Uflacker L, Rudolf H, Gatermann SG. COVID-19: hotspot hospital?\u2014seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: intermediate results of a prospective surveillance study. Int J Hyg Environ Health. 2021;235:113771.","journal-title":"Int J Hyg Environ Health"},{"key":"7057_CR20","doi-asserted-by":"publisher","first-page":"113671","DOI":"10.1016\/j.ijheh.2020.113671","volume":"232","author":"TT Brehm","year":"2021","unstructured":"Brehm TT, Schwinge D, Lampalzer S, Schlicker V, K\u00fcchen J, Thompson M, et al. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: a sequential follow-up study. Int J Hyg Environ Health. 2021;232:113671.","journal-title":"Int J Hyg Environ Health"},{"key":"7057_CR21","unstructured":"Robert Koch Institute. Corona-monitoring report: data for Berlin-Mitte 2021. Available from: https:\/\/www.rki.de\/DE\/Content\/Gesundheitsmonitoring\/Studien\/cml-studie\/Factsheet_Berlin-Mitte.html."},{"issue":"5","key":"7057_CR22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/00045632211012728","volume":"58","author":"E Heffernan","year":"2021","unstructured":"Heffernan E, Kennedy L, Hannan MM, Ramlaul N, Denieffe S, Courtney G, et al. Performance characteristics of five SARS-CoV-2 serological assays: clinical utility in health-care workers. Ann Clin Biochem. 2021;58(5):496\u2013504.","journal-title":"Ann Clin Biochem"},{"issue":"12","key":"7057_CR23","doi-asserted-by":"publisher","first-page":"e0244126","DOI":"10.1371\/journal.pone.0244126","volume":"15","author":"N Post","year":"2021","unstructured":"Post N, Eddy D, Huntley C, van Schalkwyk MCI, Shrotri M, Leeman D, et al. Antibody response to SARS-CoV-2 infection in humans: a systematic review. PLoS ONE. 2021;15(12):e0244126.","journal-title":"PLoS ONE"},{"key":"7057_CR24","unstructured":"Robert Koch Institute. Internal report: observed changes in test performance of the Euroimmun anti-SARS-CoV-2-ELISA (IgG) assay over time 2020."},{"issue":"1","key":"7057_CR25","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1038\/s41467-021-22958-8","volume":"12","author":"S Dispinseri","year":"2021","unstructured":"Dispinseri S, Secchi M, Pirillo MF, Tolazzi M, Borghi M, Brigatti C, et al. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nat Commun. 2021;12(1):2670.","journal-title":"Nat Commun"},{"issue":"12","key":"7057_CR26","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/S1473-3099(20)30589-2","volume":"20","author":"K Iversen","year":"2020","unstructured":"Iversen K, Bundgaard H, Hasselbalch RB, Kristensen JH, Nielsen PB, Pries-Heje M, et al. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study. Lancet Infect Dis. 2020;20(12):1401\u20138.","journal-title":"Lancet Infect Dis"},{"key":"7057_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2020.100013","author":"L Piccoli","year":"2021","unstructured":"Piccoli L, Ferrari P, Piumatti G, Jovic S, Rodriguez BF, Mele F, et al. Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland. Lancet Reg Health Eur. 2021. https:\/\/doi.org\/10.1016\/j.lanepe.2020.100013.","journal-title":"Lancet Reg Health Eur"},{"issue":"35","key":"7057_CR28","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.15585\/mmwr.mm6935e2","volume":"69","author":"WH Self","year":"2020","unstructured":"Self WH, Tenforde MW, Stubblefield WB, Feldstein LR, Steingrub JS, Shapiro NI, et al. Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network\u201413 academic medical centers, April\u2013June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(35):1221\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"7057_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12890-020-01237-0","volume":"20","author":"G Sotgiu","year":"2020","unstructured":"Sotgiu G, Barassi A, Miozzo M, Saderi L, Piana A, Orfeo N, et al. SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital. BMC Pulm Med. 2020;20(1):203.","journal-title":"BMC Pulm Med"},{"key":"7057_CR30","doi-asserted-by":"publisher","first-page":"100835","DOI":"10.1016\/j.eclinm.2021.100835","volume":"34","author":"AM Valdes","year":"2021","unstructured":"Valdes AM, Moon JC, Vijay A, Chaturvedi N, Norrish A, Ikram A, et al. Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk. EClinicalMedicine. 2021;34:100835.","journal-title":"EClinicalMedicine"},{"key":"7057_CR31","unstructured":"Robert Koch Institute. W\u00f6chentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19), 2 December 2021. Available from: https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Situationsberichte\/Wochenbericht\/Wochenbericht_2021-12-02.pdf?__blob=publicationFile."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07057-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07057-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07057-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T09:05:12Z","timestamp":1643015112000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07057-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7057"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07057-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"13 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent to participate. A formal ethical review process and approval was not required for this outbreak investigation in accordance with article 25, section\u00a01 of the German Protection against Infection Act (IfSG). All methods were carried out in accordance with relevant guidelines and regulations including the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}